Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
gabriella.dettorre@uniroma1.it
Gabriella D'Ettorre
Professore Ordinario
Struttura:
DIPARTIMENTO DI SANITA' PUBBLICA E MALATTIE INFETTIVE
E-mail:
gabriella.dettorre@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Myeloid and lymphoid activation markers in AIDS and non-AIDS presenters
IMMUNOBIOLOGY
2018
Prevalence of single and multiple natural NS3, NS5A and NS5B resistance-associated substitutions in hepatitis C Virus Genotypes 1-4 in Italy
SCIENTIFIC REPORTS
2018
Sa1854 - Oral Bacteriotherapy Improves Gut Inflammation and Reduces Fecal Infectivity of HIV Subjects
GASTROENTEROLOGY
2018
TREATED HIV-1 PATIENTS WITH DIFFERENT LEVELS OF VIRAL SUPPRESSION: CHANGES IN MICRORNA EXPRESSION PROFILES
abstract book Congresso SIV-ISV
2018
HIV-1 DIVERSITY AND ANTIRETROVIRAL RESISTANCE MUTATIONS AMONG TREATMENT NAÏVE PATIENTS FROM 2005-2017: A SINGLE CENTER EXPERIENCE
Abstract book SIV congress 2018
2018
Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens?
JOURNAL OF HEPATOLOGY
2018
Prevalence and predictors of long corrected QT interval in HIV-positive patients. a multicenter study
JOURNAL OF CARDIOVASCULAR MEDICINE
2017
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies
LIVER INTERNATIONAL
2017
Probiotic supplementation promotes a reduction in T-cell activation, an increase in Th17 frequencies, and a recovery of intestinal epithelium integrity and mitochondrial morphology in ART-treated HIV-1-positive patients
IMMUNITY, INFLAMMATION AND DISEASE
2017
Evaluation of HIV-DNA and inflammatory markers in HIV-infected individuals with different viral load patterns
BMC INFECTIOUS DISEASES
2017
A pilot study on the effects of probiotic supplementation on neuropsychological performance and microRNA-29a-c levels in antiretroviral-treated HIV-1-infected patients
BRAIN AND BEHAVIOR
2017
Improvement of neuropsychological performances and reduction of immune-activation markers after probiotic supplementation and change of life-style in an HIV positive male: targeting the microbiota to act on gut-brain axis
INFECTIOUS DISEASES AND TROPICAL MEDICINE
2017
Modulation of tryptophan/serotonin pathway by probiotic supplementation in human immunodeficiency virus-positive patients: preliminary results of a new study approach
INTERNATIONAL JOURNAL OF TRYPTOPHAN RESEARCH
2017
Direct-acting antiviral therapy enhances total CD4+ and CD8+ T-cells responses, but does not alter T-cells activation among HCV mono-infected, and HCV/HIV-1 co-infected patients
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY
2017
Cardiovascular risk and dyslipidemia among persons living with HIV. A review
BMC INFECTIOUS DISEASES
2017
Trans-dissemination of exosomes from HIV-1-infected cells fosters both HIV-1 trans-infection in resting CD4+T lymphocytes and reactivation of the HIV-1 reservoir
ARCHIVES OF VIROLOGY
2017
Evolution of blood-associated HIV-1 DNA levels after 48 weeks of switching to atazanavir/ritonavir+lamivudine dual therapy versus continuing triple therapy in the randomized AtLaS-M trial
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
2017
Novelties in Evaluation and Monitoring of Human Immunodeficiency Virus-1 Infection: Is Standard Virological Suppression Enough for Measuring Antiretroviral Treatment Success?
AIDS REVIEWS
2017
RE: Ectopic colonization of oral bacteria in the intestine drives Th1 induction and inflammation
SCIENCE
2017
Use of statins and aspirin to prevent cardiovascular disease among HIV-positive patients. A survey among Italian HIV physicians
NEW MICROBIOLOGICA
2017
« prima
< precedente
1
2
3
4
5
6
7
8
9
10
11
12
seguente ›
ultima »
Progetti di Ricerca
Oral bacteriotherapy decontamination for the prevention of Ventilator Associated Pneumonia (VAP) in Intensive Care Unit patients.
Studio della patologia cardiovascolare nel paziente HIV positivo: implicazioni cliniche delle modificazioni del microbiota e dei marcatori sierologici di immunoattivazione
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma